We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.31B
AUM Growth
-$51.4M
Cap. Flow
-$54.7M
Cap. Flow %
-4.18%
Top 10 Hldgs %
12.11%
Holding
1,682
New
422
Increased
338
Reduced
347
Closed
506

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$18.2M
2
TER icon
Teradyne
TER
+$15.9M
3
BE icon
Bloom Energy
BE
+$15.3M
4
CYBR
CyberArk
CYBR
+$15.2M
5
EXAS
Exact Sciences
EXAS
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 14.62%
3 Consumer Discretionary 10.89%
4 Industrials 8.81%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTRE icon
576
Fortrea Holdings
FTRE
$1.82B
$424K 0.03%
+45,016
New +$579K
CTVA icon
577
Corteva
CTVA
$52.6B
$424K 0.03%
5,064
-5,310
-51% -$400K
CVGW
578
DELISTED
Calavo Growers
CVGW
$423K 0.03%
16,400
+2,524
+18% +$63.2K
NKE icon
579
Nike
NKE
$61.9B
$423K 0.03%
8,000
+4,702
+143% +$285K
PBI icon
580
Pitney Bowes
PBI
$2.4B
$422K 0.03%
38,218
-3,994
-9% -$41.9K
MNST icon
581
Monster Beverage
MNST
$94.3B
$422K 0.03%
5,820
+3,000
+106% +$237K
AVNT icon
582
Avient
AVNT
$3.33B
$421K 0.03%
+11,594
New +$430K
GIS icon
583
General Mills
GIS
$19.1B
$419K 0.03%
+11,268
New +$489K
FBIN icon
584
Fortune Brands Innovations
FBIN
$5.88B
$419K 0.03%
10,744
+2,828
+36% +$147K
GENI icon
585
Genius Sports
GENI
$1.85B
$418K 0.03%
94,275
-11,896
-11% -$84.7K
ABEO icon
586
Abeona Therapeutics
ABEO
$366M
$417K 0.03%
93,073
-18,106
-16% -$90.5K
TMO icon
587
Thermo Fisher Scientific
TMO
$213B
$411K 0.03%
836
-822
-50% -$446K
RDDT icon
588
Reddit
RDDT
$27.1B
$410K 0.03%
3,046
-2,140
-41% -$364K
MTN icon
589
Vail Resorts
MTN
$5.32B
$409K 0.03%
3,188
-1,669
-34% -$228K
DVN icon
590
Devon Energy
DVN
$52.1B
$408K 0.03%
8,114
-9,444
-54% -$405K
FE icon
591
FirstEnergy
FE
$28B
$407K 0.03%
+8,042
New +$390K
TER icon
592
Teradyne
TER
$57.6B
$407K 0.03%
1,374
-56,961
-98% -$15.9M
PINS icon
593
Pinterest
PINS
$13.4B
$407K 0.03%
22,200
-37,737
-63% -$788K
TBPH icon
594
Theravance Biopharma
TBPH
$874M
$406K 0.03%
+25,000
New +$442K
QGEN icon
595
Qiagen
QGEN
$8.54B
$405K 0.03%
+10,124
New +$479K
ONTF
596
DELISTED
ON24
ONTF
$405K 0.03%
50,000
+18,538
+59% +$148K
NI icon
597
NiSource
NI
$21.3B
$405K 0.03%
8,672
-37,815
-81% -$1.7M
GOOG icon
598
PUT
Alphabet (Google) Class C
GOOG
$4.36T
$404K 0.03%
+92
New +$28.9K
STRZ
599
Starz Entertainment Corp
STRZ
$437M
$404K 0.03%
35,101
+13,647
+64% +$152K
KLAC icon
600
KLA
KLAC
$239B
$403K 0.03%
2,740
-31,120
-92% -$4.55M

Similar funds

Prelude Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Prelude Capital Management held 1,682 positions worth $1.31B, down 3.8% from $1.36B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $54.7M in Q1 2026, closing 506 positions and reducing 347 holdings. Its most notable exit was CyberArk, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Appian worth $9.41M.

  • Prelude Capital Management's largest Q1 2026 buy was Appian: 390,321 shares worth $9.41M.
  • Prelude Capital Management added most to Penumbra in Q1 2026, an estimated $15.3M increase.
  • Prelude Capital Management's biggest Q1 2026 reduction was SPDR Gold Trust, cutting an estimated $18.2M.
  • Prelude Capital Management fully exited CyberArk in Q1 2026, selling an estimated $15.2M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.31B portfolio in Q1 2026.
  • Prelude Capital Management opened 422 new positions and closed 506 in Q1 2026.
  • Prelude Capital Management's portfolio value fell 3.8% quarter-over-quarter to $1.31B.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.